Chimeric antigen receptor T-cell therapy for solid tumors
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine
Reference75 articles.
1. Immune checkpoint blockade: a common denominator approach to cancer therapy;Topalian;Cancer Cell,2015
2. A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes;Willemsen;Gene Ther,2001
3. Chimeric antigen receptor T cell therapy: 25 years in the making;Gill;Blood Rev,2015
4. The evolution of T-cell therapies for solid malignancies;Fousek;Clin Cancer Res,2015
5. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma;Louis;Blood,2011
Cited by 198 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking;PET Clinics;2024-10
2. Revolutionizing Immunotherapy: Unveiling New Horizons, Confronting Challenges, and Navigating Therapeutic Frontiers in CAR-T Cell-Based Gene Therapies;ImmunoTargets and Therapy;2024-08
3. Cancer therapy-related cardiac dysfunction and the role of cardiovascular imaging: systemic review and opinion paper from the Working Group on Cardio-Oncology of the Korean Society of Cardiology;Journal of Cardiovascular Imaging;2024-07-30
4. Adverse events associated with chimeric antigen receptor T-cell therapy in ophthalmology: a narrative review;Annals of Medicine & Surgery;2024-05-20
5. Engineering multifunctional dynamic hydrogel for biomedical and tissue regenerative applications;Chemical Engineering Journal;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3